Details of the Drug | DrugMAP

General Information of Drug (ID: DMUU3KJ)

Drug Name

FX-006

Indication

Disease Entry	ICD 11	Status	REF
Pain	MG30-MG3Z	Phase 3	[1]
------------------------------------------------------------------------------------

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C24H31FO6
Canonical SMILES: CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)C
InChI: 1S/C24H31FO6/c1-20(2)30-19-10-16-15-6-5-13-9-14(27)7-8-21(13,3)23(15,25)17(28)11-22(16,4)24(19,31-20)18(29)12-26/h7-9,15-17,19,26,28H,5-6,10-12H2,1-4H3/t15-,16-,17-,19+,21-,22-,23-,24+/m0/s1
InChIKey: YNDXUCZADRHECN-JNQJZLCISA-N

Cross-matching ID

PubChem CID: 6436
ChEBI ID: CHEBI:71418
CAS Number: 76-25-5
TTD ID: D08YWK

References

1	ClinicalTrials.gov (NCT02357459) Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee. U.S. National Institutes of Health.